VirusesHumansChikungunya FeverChikungunya virusAntiviral AgentsViral Vaccines
Chikungunya in 2025: Comprehensive Insights into Virology, Diagnostics, Vaccines, and Antiviral Therapies.
Zeyong Zheng, Hua Ji, Zeping Shan, Jiangcheng Xu, Jiarui Li, Xueting Zhang, Jiajia Zheng, Shibo Jiang, Naru Zhang
Published: 202610.3390/v18010100
Abstract
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus prevalent in more than 110 countries and regions, including Africa, Asia, the Americas, and Europe. It can cause acute fever, rash, and severe joint pain, and some patients may develop chronic…
Preview only. Read the full abstract at the source